Cornwall Trade and Investment is supporting the flourishing health technology sector in Cornwall. In Cornwall there is an active healthtech ecosystem, with key local partners, business support programmes and funding opportunities to help healthtech innovators get their business and product market ready for the NHS.
Cornwall Trade and Investment wanted to appoint an experienced Healthtech consultancy to support the team to promote the brilliant healthtech proposition in Cornwall and to work directly with innovators to help navigate the UK Health Service landscape.
Selling a solution into the NHS is the ultimate seal of approval, making it both a lucrative business opportunity and a sure-fire way of proving the value of a product or service around the world.
But it can be a complex system to navigate. And there is currently no mandate for digital products to be adopted by the NHS, even if it saves time, money and improves patient outcomes.
Healthwave is a team of experienced NHS clinicians, technology specialists and managers with decades of front line and health system management expertise which spans over 40 years. Our consultancy services combine market analysis, networking and business development to ensure success for entrants to the UK healthtech market.
To support Cornwall Trade and Investment to triage leads Healthwave developed an assessment tool to categorise inward investors and assess their UK adoption readiness. This approach assists Cornwall Trade and Investment to triage leads, better understand the type of technology in development and guide inward investors to the best landing place within Cornwall’s healthtech ecosystem.
Our overall approach provides a funnel into the system for healthtech innovators to pass through, triaging their needs and priorities to the correct source of engagement and support. Healthwave is able to leverage its strong local networks, digital health market expertise and extensive clinical knowledge to match innovators to relevant stakeholders to support the onward journey into the UK healthcare market.